Journal: Blood
Article Title: Aberrant mural cell recruitment to lymphatic vessels and impaired lymphatic drainage in a murine model of pulmonary fibrosis
doi: 10.1182/blood-2011-12-396895
Figure Lengend Snippet: (A) Quantitative analysis of the PDGFR-P expression in isolated lymphatic endothelial cells of bleomycin-treated (Bleo) and healthy control mice at day 28 (controls n = 15; Bleo n = 14). Immunostaining of PDGF-B (B) or PDGFR-β (C) and lymphatic vessels (VEGFR3) on lung tissue of fibrotic and control mice at day 28. Scale bars equal 100 μm. (D) Westernblot of phospho–PDGFR-β and total PDGFR-β of whole lung lysates at day 28 after treatment with bleomycin or PBS, respectively (controls n = 5; Bleo n = 13). (E) Quantitative analysis of the ratio of phospho–PDGFR-β to total PDGFR-β at day 28 after treatment with bleomycin or PBS (controls n = 5, Bleo n = 13). (F) Double-immunodetection of phospho–PDGFR-β and lymphatic vessels (VEGFR3) on healthy and fibrotic murine lung tissue at day 28. Scale bars equal 100 μm. Quantitative analysis of Lyve-1–positive lymphatic vessels (G), VEGFR3-positive lymphatic vessels (H) or Prox1-positive lymphatic vessels (I) covered with SMA-positive mural cells at day 28 after treatment with bleomycin, bleomycin + AG-1296 (Bleo + AG-1296; 10 mg/kg body weight twice a week intraperitoneally; 0.5 ng, 5 times per week intraperitoneally, starting at day 14 after first bleomycin injection) or in healthy control lungs of PBS-treated mice (controls n = 15; Bleo n = 29, Bleo + AG-1296, n = 13). Error bars show SEM.
Article Snippet: Primary antibodies used in this study were as follows: rabbit polyclonal to Lyve-1 at a 1:200 dilution (Abcam), anti-laminin antibody at a 1:50 dilution (Sigma-Aldrich), goat polyclonal to mouse serum albumin at a 1:500 dilution (Abcam), mouse mAb phospho-PDGFR-β at a 1:100 dilution (Cell Signaling), rabbit monoclonal antibody (mAb) PDGFR-β at a 1:100 dilution (Cell Signaling), rabbit polyclonal to PDGF BB at a 1:100 dilution (Abcam), rat anti–mouse VEGFR3 at a 1:100 dilution (BD Bioscience), human Prox1 affinity purified polyclonal AB goat immunoglobulin (Ig) G at a 1:200 dilution (R&D Systems), anti–mouse α-SMA at a 1:500 dilution (Chemicon), biotinylated hyaluronan-binding peptide at a 1:100 dilution (Calbiochem), D2-40 and S100A4 (FSP) at a 1:200 dilution (Dako).
Techniques: Expressing, Isolation, Control, Immunostaining, Immunodetection, Injection